Prothena Corp. plc (PRTA), a late-stage clinical biotechnology company, has multiple data readouts scheduled for the coming quarters across four clinical programs.
The company's pipeline comprises of therapeutic candidates for a number of neurodegenerative and rare peripheral amyloid diseases.
The Neurodegenerative Diseases Portfolio includes PRX012, BMS-986446 (formerly PRX005), PRX123, Prasinezumab, and PRX019.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.